Skip to content
healthcare.dev

Silenor

NDC 42847-103, doxepin hydrochloride, tablet, from Currax Pharmaceuticals LLC.

Product NDC
42847-103
Status
Listed
Labeler
Currax Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022036
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42847-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXEPIN HYDROCHLORIDE3 mg/1

Pharmacologic classes

Tricyclic Antidepressant [EPC]

Package NDCNDC-11Package
42847-103-034284701030330 TABLET in 1 BLISTER PACK (42847-103-03)
42847-103-1042847010310100 TABLET in 1 BOTTLE (42847-103-10)
42847-103-304284701033030 TABLET in 1 BOTTLE (42847-103-30)
42847-103-5042847010350500 TABLET in 1 BOTTLE (42847-103-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1bec1223-5239-4eb6-a9e8-62444106d2c0

Use it

Look up 42847-103 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42847-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42847-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.